Diamedica Inc. TSX.V DMA

Tags: Mid-Canada, mid, canada, investment, forum, winnipeg, manitoba, biomedica, inc, tsx.v, dma, diabetes, type, 2, medical, life, science, sciences, kevin, richardson

Kevin Richardson, Investor Relations

DiaMedica is developing novel treatments for various stages of Type 2 diabetes. Based on its newly discovered mechanism, the Company has been issued two U.S. patents and currently has 35 pending patents worldwide for a broad range of diabetes and related metabolic disorders including obesity and hypertension.

Sector: Life Sciences
Main Exchange: TSX.V DMA
Secondary Listing: N/A

Added: 14th November 2008
Views: 411